Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (1) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (6) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Rhein, Simone Dr. (1) Schmitt, Clemens Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (2) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (20) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (9) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (20) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Tumorgenetik und zelluläre Stressantworten (1) 1992 (4) 1993 (7) (-) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) (-) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (5) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 20 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 1994201220152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein 01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni 01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein 01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein 30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm 01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni
01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein
01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein
30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein